Year: 2025
Type: article
Abstract: The behavior of nuclei and electrons is described by quantum mechanics, which also provides an explanation of the distribution and motion of molecular interactions. It is essential to comprehend the bonding electronic orbitals of atoms and molecules as well as to characterize the quantized energy levels. Significant progress has been made in the past ten years in applying quantum mechanics (QM) to biological issues that have medicinal implications. The goal of this review paper is to demonstrate how ligand-receptor interactions can be better understood using QM-based techniques. The next step is to apply this knowledge to the structure-based design of novel and powerful inhibitors, like transition state (TS) analogues that mimic the enzyme TS’s structure and physicochemical characteristics. Considering the outcomes and promise that QM has so far expressed. The implementation of QM in structure-based drug design will probably rise given the outcomes and promise shown thus far by QM-based methods in studying biological challenges, turning these formerly prohibitively expensive computations into a regularly used tool for drug design. The idea and uses of quantum mechanics in the pharmaceutical and drug design fields are highlighted in this article.
Language: English
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
Open Access status: hybrid
OpenAlex ID: W4407606147